Exelixis Inc (EXEL)
23.71
+0.42
(+1.80%)
USD |
NASDAQ |
Apr 24, 16:00
23.70
0.00 (0.00%)
After-Hours: 20:00
Exelixis Cash from Investing (TTM): -26.96M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.96M |
| September 30, 2023 | -334.47M |
| June 30, 2023 | -438.11M |
| March 31, 2023 | -499.47M |
| December 31, 2022 | -524.41M |
| September 30, 2022 | -291.69M |
| June 30, 2022 | -243.98M |
| March 31, 2022 | -179.68M |
| December 31, 2021 | -42.88M |
| September 30, 2021 | -59.34M |
| June 30, 2021 | -245.70M |
| March 31, 2021 | -101.58M |
| December 31, 2020 | -131.22M |
| September 30, 2020 | -231.91M |
| June 30, 2020 | -230.77M |
| March 31, 2020 | -446.97M |
| December 31, 2019 | -587.25M |
| September 30, 2019 | -599.84M |
| June 30, 2019 | -456.64M |
| March 31, 2019 | -379.97M |
| December 31, 2018 | -297.85M |
| September 30, 2018 | -173.38M |
| June 30, 2018 | -136.72M |
| March 31, 2018 | -23.24M |
| December 31, 2017 | 36.80M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.782M |
| June 30, 2017 | 10.68M |
| March 31, 2017 | -160.36M |
| December 31, 2016 | -214.55M |
| September 30, 2016 | -131.63M |
| June 30, 2016 | -151.01M |
| March 31, 2016 | -19.50M |
| December 31, 2015 | 50.08M |
| September 30, 2015 | 56.24M |
| June 30, 2015 | 98.86M |
| March 31, 2015 | 135.86M |
| December 31, 2014 | 146.33M |
| September 30, 2014 | 175.66M |
| June 30, 2014 | 182.58M |
| March 31, 2014 | 138.36M |
| December 31, 2013 | 144.35M |
| September 30, 2013 | -14.78M |
| June 30, 2013 | -174.02M |
| March 31, 2013 | -140.84M |
| December 31, 2012 | -259.47M |
| September 30, 2012 | -122.47M |
| June 30, 2012 | 51.30M |
| March 31, 2012 | -72.24M |
| December 31, 2011 | -51.46M |
| September 30, 2011 | -82.44M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-599.84M
Minimum
Sep 2019
-26.96M
Maximum
Dec 2023
-298.57M
Average
-245.70M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
| Regeneron Pharmaceuticals Inc | -3.185B |
| Bristol-Myers Squibb Co | -2.295B |
| Johnson & Johnson | 878.00M |
| Bio-Techne Corp | -423.63M |
| Legend Biotech Corp | 92.79M |